Video Experimental Relacionado
Updated: Jan 7, 2026
09:43
Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
12.5K
Hemo como activador y objetivo de la artemisinina: Hacia una actividad biológica farmacológica múltiple
Pan Zhu1, Xinyi Sun1, Yuting Fang1
1School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, 214122, China.
Biochemistry and biophysics reports
|January 1, 2026
Resumen
La artemisinina, derivada de Artemisia annua, muestra promesa en nuevas terapias. Su estructura única interactúa con el hemo, desbloqueando aplicaciones potenciales antifúngicas, anticancerígenas y antivirales.
Área de la Ciencia:
- Farmacología y Química de Productos Naturales
- Química Medicinal
- Descubrimiento de Fármacos
Sus antecedentes:
- La artemisinina, una sesquiterpeno trioxano de *Artemisia annua*, tiene un puente de peróxido único.
- Su actividad biológica se media principalmente a través de la interacción con el hemo.
- La artemisinina tiene un perfil de seguridad clínica probado, lo que fomenta la investigación de nuevos usos terapéuticos.
Objetivo del estudio:
- Revisar las acciones farmacológicas de la artemisinina, centrándose en la interacción con el hemo.
- Explorar el potencial de la artemisinina en tratamientos antifúngicos, anticancerígenos y antivirales.
- Proporcionar información para el desarrollo de nuevos productos farmacéuticos y estrategias terapéuticas.
Principales métodos:
- Revisión de la literatura sobre los mecanismos de acción de la artemisinina.
- Análisis de estudios que investigan la interacción de la artemisinina con el hemo.
- Síntesis de la investigación actual sobre las diversas actividades biológicas de la artemisinina.
Principales resultados:
- El puente de peróxido de la artemisinina es crucial para su actividad biológica a través de la interacción con el hemo.
- La evidencia respalda el potencial de la artemisinina como agente antifúngico, anticancerígeno y antiviral.
- El mecanismo centrado en el hemo proporciona un marco para comprender su eficacia general.
Conclusiones:
- La interacción con el hemo es clave para comprender los diversos efectos farmacológicos de la artemisinina.
- La artemisinina tiene un potencial significativo para el desarrollo de nuevos tratamientos para diversas enfermedades.
- Se justifica una mayor investigación sobre las terapias basadas en artemisinina para la innovación farmacéutica.
Videos de Conceptos Relacionados
01:24Principles of Drug Action
7.8K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.8K
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
01:30Drug Binding to Blood Components
472
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
472
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
879
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
879